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Abstract
Background—The association of central adiposity with incident heart failure (HF) has yet to be
studied in a large population-based study.
Methods and Results—The Atherosclerosis Risk in Communities (ARIC) study is an ongoing
bi-racial population-based cohort of those aged 45–65 years from 4 U.S. communities with 16 years
median follow-up for incident, hospitalized or fatal HF. Waist-hip ratio (WHR), waist circumference
and body mass index (BMI) were measured baseline (1987–1989). After exclusions the sample size
was 14,641. BMI was categorized as BMI < 25, BMI 25–29.9, and BMI ≥ 30 (kg/m2). Waist
circumference and WHR were divided into gender-specific tertiles. A first occurrence of ICD-9-CM
codes of HF, either hospital discharge (428.0–428.9, N=1,451), or on a death certificate (428.0–428.9
or I50.0–I50.9, N=77) was considered an HF event. Cox models were adjusted for alcohol use,
smoking, age, center, and educational level. The adjusted hazard ratios (HR) for the highest category
(obese) compared to the lowest were well above 1.0 for all three anthropometric measures (HR for
3rd vs. 1st tertile of WHR: 2.27 (1.71, 3.02), white women; 3.24 (2.25, 4.65); black women; 2.46
(1.95, 3.09), white men; and 2.63 (1.90, 3.65), black men). Hazard ratios for overweight were lower
in magnitude suggesting a graded response between body size and HF.
Conclusions—Obesity and overweight, as measured by three different anthropometrics, were
associated with incident HF in the ARIC cohort. The current study does not support the superiority
of WHR and waist circumference over BMI for the prediction of incident HF.
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Obesity, as measured by body mass index (BMI), has been identified as a risk factor for heart
failure (HF) from the Framingham Heart Study1 and other studies2, 3. The increasing
prevalence of both obesity and HF in the U.S. make this association an important topic for
prevention4. Replication of the association of obesity with HF in non-white racial groups has
been mentioned as an important area for future research5.
Furthermore, research on the association of measures of central adiposity with HF has been
mentioned as a priority research area6. Because diabetes and insulin resistance are risk factors
for HF7, 8, one would expect that a measure of central adiposity, a correlate of impaired insulin
sensitivity, would have a stronger association with incident HF than a measure of generalized
adiposity. Waist circumference is highly correlated with BMI and is therefore considered a
measure of both central and generalized adiposity, whereas waist-hip ratio (WHR) is a measure
of central adiposity only9. Existing studies imply that waist circumference and WHR are also
associated with incident HF8, 10, 11, however results vary depending on the population under
study.
The Atherosclerosis Risk in Communities (ARIC) study is a bi-racial longitudinal cohort study
of cardiovascular disease and its risk factors in those aged 45–65 years. It has anthropometric
measures of BMI, WHR, and waist circumference from the baseline visit along with 16 years
median follow-up for incident HF. In this study, we evaluated the race- and gender-specific
associations of overweight and obesity with incident HF. Furthermore, we determined whether
a measure of central adiposity (WHR) or a measure of generalized and central adiposity (waist
circumference) would be more closely associated with incident HF than BMI.
2. Methods
Study Population
The ARIC cohort (N=15,792) was recruited between 1987–1989 using probability sampling
of those aged 45–64 years from the following four US communities: Forsyth County, North
Carolina; Jackson, Mississippi; suburbs of Minneapolis, Minnesota; and Washington County,
Maryland. The distribution of blacks and whites from each field center was representative of
the area (mostly white in Minneapolis and Washington County, 15 % black in Forsyth County),
except in Jackson where only blacks were sampled. Response rates at baseline were 46 % in
Jackson and between 65–67 % for the other communities. Three subsequent visits were
conducted at approximately three-year intervals (last visit in 1996–98). The design and
rationale of the ARIC study 12 and a comparison of responders and nonresponders 13 have been
previously published. The institutional review boards from each site approved the ARIC study.
All participants provided written informed consent.
Racial groups not classified as white or black (N = 48), and blacks not from Jackson or Forsyth
County (N = 120) were excluded in this study due to their limited numbers. Those with missing
anthropometry (N = 33), prevalent HF at baseline (N=751), or missing criteria used to define
prevalent HF (N=289) were excluded. Criteria to define prevalent HF were as follows: 1) those
answering “yes” to the following question: “Were any of the medications you took during the
last two weeks for HF?” (N = 83), or 2) those with stage 3 HF by applying Gothenburg criteria
(N = 699)14. Gothenburg criteria were defined by self-reported medical history, medication
lists and electrocardiography15. After these exclusions, the total sample size was 14,641.
Anthropometric Measures
Anthropometric indices were measured after an overnight fast with participants in standard
scrub attire. Technicians measured height with participants barefoot using a wall mounted ruler.
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An anthropometric measuring tape was applied horizontally to measure hip and abdominal
girth; participants stood upright with weight evenly distributed between both feet and breathing
quietly. Abdominal girth was measured at the level of the umbilicus and hip girth at the level
of maximal protrusion of the gluteal muscles. Weight was measured using a scale (Detecto
model 437) that was zeroed daily and calibrated quarterly. Body mass index (BMI) was
calculated as weight divided by height squared (kilograms/meters2), whereas WHR was the
waist girth divided by the hip girth. Inter-technician reliability coefficients for waist and hip
girth and WHR were >0.9116.
Ascertainment of heart failure events
The following methods were used for ascertainment of HF events: 1) participants were
interviewed annually by phone about interim hospitalizations (93–96 % response); 2) local
hospitals provided lists of hospital discharges with cardiovascular diagnoses and these were
reviewed to identify cohort hospitalizations; and 3) health department death certificate files
were continuously surveyed. All discharge diagnosis codes for cohort hospitalizations and
underlying or contributory causes of death from death certificates were recorded.
Incident heart failure event criteria
Incident HF was defined as the first occurrence of either: 1) a hospitalization which included
an ICD-9-CM (International Classification of Diseases, 9th revision, clinical modification)
discharge diagnosis code for HF beginning with `428' (i.e. 428.0 to 428.9) in any position (N
= 1,451) or else 2) a death certificate ICD-9 code beginning with `428' (HF) or ICD-10 code
`I50' (HF or I50.0 to I50.9) in any position (N = 77). Follow-up time for incident HF events
was defined as the time from their baseline examination until the incident event. The date of
censoring for those without HF was the first occurrence of either: date of last contact or death,
or December 31st, 2004. Secondary analyses inclusive of a broader range of HF ICD-9 codes
resulted in only 139 additional events. These codes were as follows: rheumatic heart failure
(398.91), hypertensive heart disease (402.01, 402.11, 402.91), cardiomyopathy (425), acute
edema of the lung (518.4) and cardiac failure postoperatively (997.1).
Baseline covariate definitions
All covariates were collected from the baseline visit. Race was self-reported; educational level,
alcohol use, and smoking status were obtained with interviewer-administered questionnaires.
History of myocardial infarction (MI) included self-report of physician-diagnosed MI or silent
MI identified by electrocardiography. Past coronary heart disease (CHD) included a history of
MI, coronary revascularization or coronary artery bypass surgery.
Hypertension was defined by either a diastolic blood pressure ≥ 90 mm Hg or a systolic blood
pressure ≥ 140 mm Hg measured with random-zero mercury manometers, or recent anti-
hypertensive medication use. Left ventricular hypertrophy was identified by
electrocardiography using Cornell criteria 17. Diabetes mellitus was defined as either: self-
reported physician-diagnosed diabetes, recent diabetes medication use, a blood glucose ≥ 126
mg/dl fasting or ≥ 200 mg/dl non-fasting. Cholesterol measurements were performed after an
overnight fast12.
Statistical Analysis
Pearson correlation coefficients were estimated to determine the correlation between BMI,
WHR and waist circumference. Multivariable Cox proportional hazard regression was used to
model the association between each anthropometric variable (BMI, WHR and waist
circumference) and time to incident HF, after stratification by race and gender. Waist
circumference, BMI and WHR were analyzed as both continuous and categorized variables.
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BMI was categorized as normal weight (< 25 kg/m2), overweight (25 – 29.9 kg/m2) and obese
(≥ 30 kg/m2), as represented in the clinical guidelines from the National Institutes of
Health18. Waist circumference and WHR were categorized into approximate gender-specific
tertiles11. Furthermore, BMI categories of normal weight, overweight and obese, were
stratified by low and high WHR using gender-specific cutpoints from the U.S. Department of
Agriculture (WHR cutpoints: women, 0.88; men, 0.95)19. For comparability between sex
and race-groups, HF incidence rates were age-adjusted to the mean age at baseline (54 years)
with Poisson models. Log (-log) survival curves and time interaction terms for the main
exposures and all covariates were used to verify the proportional hazards assumption.
The predictive ability of each anthropometric variable for incident HF was compared using
time-dependent receiver operating characteristic (ROC) curves for estimation of area under
the curve at 10 years (AUC(10)), as described by Chambless and Diao20. We determined the
AUC(10) for each anthropometric measure (categorized) based on predicted probabilities
estimated from gender-stratified multivariable Cox proportional hazards models. Predicted
probabilities at 10 years were divided into deciles and each compared to the lowest group.
Goodness of fit was assessed using Hosmer-Lemeshow tests. Furthermore, we adjusted for
optimism due to use of the same dataset for determination of AUC(10) for both models being
compared21.
To assess for additive effect measure modification by race, interaction contrast ratios22 (ICR)
with 95 % CIs were calculated. A probabilistic sensitivity analysis was performed to assess
the impact of systematic error from nondifferential outcome misclassification. A method
developed by Lash and Fink23 was used to incorporate uncertainty from outcome
misclassification into traditional regression using Monte Carlo uncertainty analysis. All
statistical analyses were performed using SAS software v 9.1 (Cary, NC).
The authors had full access to the data and take responsibility for its integrity. All authors have
read and agree to the manuscript as written.
3. Results
Those who developed HF were older at baseline, more likely to be black, male, and less well
educated (Table 1). As would be expected, there was a higher percentage of CHD and
cardiovascular risk factors among HF events. Waist circumference and WHR cutpoints for
men were higher than they were for women (Table 2). The mean value for each anthropometric
by anthropometric category was surprisingly similar by gender and across race. For all race
and gender groups, age-adjusted HF incidence rates were two-to three-fold higher when
comparing the lowest group to the highest for all three measures (Table 2). Across all three
anthropometric exposures, HF incidence rates were higher in blacks compared to whites for
both men and women. The HF incidence rates in black women compared to white women were
nearly two-fold higher for all measures.
Adjusted hazard ratios for the comparison of the highest anthropometric category (obese) to
the lowest for all three measures were well above 1.0 for all race and gender groups (Table 3,
Figure 1). In fact, when combined across race, the adjusted hazard ratios for HF with obesity
were all well above 2.0. Hazard ratios for the middle category (overweight) for all three
anthropometric measures tended to be intermediate, thus suggesting a graded response between
body size and HF (Table 3). Calculation of interaction contrast ratios and interaction term
analysis (P > 0.05) did not provide evidence for additive or multiplicative effect measure
modification by race. Although we did not find such support for differences by race, for
completeness, we present race- and gender-stratified estimates of the association of HF and
adiposity.
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Multivariable models of each anthropometric measure in continuous form showed positive
associations for all race and gender groups (Table 3). For better comparability across measures,
a one standard deviation (SD) increment (gender-specific) in each baseline anthropometric was
modeled, rather than a one unit change in each measure. After adjustment for confounding
factors, women with a 1 SD (0.08) higher WHR were 59 % more likely to develop incident
HF over the next 16 years, whereas men with a 1 SD higher WHR (0.05) were 50 % more
likely to develop incident HF. Results were similar for BMI and waist circumference. To refute
the hypothesis that obesity at baseline was due to fluid retention from HF, we excluded the
first three years of follow-up and found little change in the associations examined here (results
not shown).
Waist circumference and BMI were highly correlated (r = 0.88), WHR and waist circumference
were moderately correlated (r= 0.73), and BMI and WHR were relatively poorly correlated (r
= 0.43). Stratification of BMI by waist circumference resulted in small sample sizes for certain
categories; instead we describe HF incidence rates for BMI categories, stratified by high and
low WHR. Age-adjusted HF incidence rates for categories of BMI, stratified by high and low
WHR show an increasing trend across these categories, with a particularly high HF incident
rate (10.5 per 1,000 person-years) in those with both a high BMI and WHR (Figure 2).
Estimation of AUC(10) from predicted probabilities from multivariable models for each
anthropometric were as follows: BMI (0.73 for men, 0.79 for women); WHR (0.74 for men,
0.79 for women); waist circumference (0.73 for men, 0.79 for women); and BMI stratified by
high and low WHR (0.74 for men, 0.79 for women). By gender, there were no pronounced
differences in AUC(10) between the three measures, or when compared to models with cross-
classified categories of BMI and WHR (P>0.05 for all comparisons). Results were similar
when stratified by race and gender. Of note, in some cases, the Hosmer-Lemeshow tests did
not support good model fit.
The sensitivity analysis assessed the effect of outcome misclassification on the multivariable
association between obesity (BMI ≥ 30) and HF. Misclassification was assumed
nondifferential, meaning it did not depend on values of other variables (namely, BMI) or on
errors in measuring them. The selected distributions of the sensitivity parameters for
misclassification of HF were initially based on findings from the literature; subsequently, the
specified distributions required modification to allow for selection of plausible combinations
of the sensitivity parameters (sensitivity: minimum =0.6, mode 1 =0.7, mode 2 =0.85,
maximum =1; for specificity, minimum =0.94, mode 1 =0.96, maximum=1)24. The sensitivity
analysis results show the median odds ratio (OR) was higher and the 2.5th and 97.5th percentiles
much farther apart (OR =4.54, 95 % uncertainty interval =2.93, 14.83) than the results of the
conventional analysis (OR =2.89, 95 % CI =2.47, 3.42), which assumes with complete certainty
that outcome classification is perfect. As expected, this suggests that the effect of outcome
misclassification on our findings, given the chosen distributions of sensitivity and specificity,
was to bias them towards the null, and that the assumption of perfect outcome classification in
the conventional analysis understates the actual uncertainty about the true value of the OR. In
secondary analyses using the expanded definition of HF (inclusive of a broader range of ICD
codes), there were no appreciable differences in any of our findings (results not shown).
4. Discussion
Generalized obesity and central adiposity, as measured by three different anthropometric
measures, were associated with incident HF over16 years median follow-up of the ARIC
cohort. The magnitudes and patterns of the associations were similar for all three measures and
there was evidence of a graded relation for all race, gender groups. Furthermore, an adverse
association existed between adiposity and incident HF even for those who were overweight
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compared to normal weight, although this finding was less consistent across stratified
analyses. Analyses of ROC curves found no important differences in the prediction of incident
HF for the three measures. This implies that measures of WHR and waist circumference are
not superior to BMI in the prediction of HF. This is contrary to our hypothesis that measures
of central adiposity will be more closely associated with HF due to their closer association with
diabetes, a known HF risk factor. This suggests that beyond the metabolic derangements
associated with central adiposity, other mechanisms associated with generalized adiposity,
must play a role in mediating the relationship between obesity and HF.
Several previous studies with BMI measures have found similar associations to those observed
here. The Framingham Heart Study found that overweight and obesity as measured by BMI
were associated with an increased risk for HF over 14 years median follow-up; multivariable
adjusted hazard ratios were 1.34 (95 % CI = 1.08, 1.67) and 2.04 (95 % CI =1.59, 2.63),
respectively1. In these models, the Framingham study adjusted for diseases along the causal
pathway between obesity to HF. As they note, adjustment for factors along the causal pathway
may underestimate the effect of adiposity with HF. Study differences between the Framingham
study and ours include that the outcome of HF from the Framingham study was validated using
Framingham criteria. The Framingham Heart Study is a primarily white population from a
single community that is approximately a third the size of the ARIC study. Since the ARIC
study included blacks and whites from 4 US communities, one might expect to find more
heterogeneity in the findings between these two studies. Instead the robustness of these findings
supports a lack of differences in this association by race.
The Renfrew-Paisley study, a community-based study from Scotland, observed an association
of obesity (as defined by BMI) with HF (HR = 2.16, 95 % CI =1.57, 2.57 for men; HR = 1.37,
95 % CI =1.00, 1.88 for women)3. The First National Health and Nutrition Examination Survey
(NHANES I) studied the association of excess BMI and incident HF2, using a dichotomous
cut-point for BMI (27.8 kg/m2 in men, 27.3 kg/m2 in women); their findings were similar to
that observed in our overweight group despite the differing cutpoints used.
To date, studies of central obesity and HF have involved less generalizable populations. For
example, the Health, Aging and Body Composition Study (Health ABC) is a longitudinal
cohort study of those aged 70–79 without CHD, in which multiple metrics of overweight/
obesity and body composition were measured10. This study had a limited number of HF events
(N = 166), in part due to the exclusion of those with CHD, a common HF precursor25. Despite
the small sample size, BMI, waist circumference, and waist/thigh ratio were all positively
associated with HF incidence. In contrast, a study of participants with CVD from the Heart
Outcomes Prevention Evaluation (HOPE) study did not find an association between obesity
and incident HF (N=297 HF events) for BMI or WHR, except there seemed an effect for WHR
in women (HR = 2.30, 95 % CI = 1.25, 4.21) 11.
We also describe risk groups using the cross-classification of two anthropometric measures,
BMI and WHR. We find that incidence rates increase across categories of BMI stratified by
WHR, however the ROC analysis does not support better prediction of incident HF with this
cross-classification of BMI and WHR as compared to these measures alone.
Further support for the association of obesity with HF comes from echocardiographic studies.
Specifically, results from the Framingham Heart Study found positive correlations between
obesity (BMI > 30 kg/m2) and echocardiographic measures of left ventricular mass, which
were also associated with increase in left ventricular internal dimensions, and wall
thickness26. A small study in normotensive men reported stronger positive correlations of left
ventricular mass with WHR and waist circumference as compared to BMI 27. Recently,
McGavock and others found that cardiac steatosis as seen with magnetic resonance
Loehr et al. Page 6













spectroscopy occurs with impaired glucose tolerance even before the development of type 2
diabetes mellitus and/or left ventricular dysfunction28.
Obesity's role in the development of HF may be through either direct and/or indirect
mechanisms. The indirect mechanisms are those in which obesity causes other diseases, such
as diabetes29, hypertension30 or CHD, which are themselves risk factors for HF25. A direct
mechanism might be that cardiac adaptation to excess body fat can result in decreased cardiac
function31. This has been termed obesity cardiomyopathy32. A novel hypothesis is that an
increase in inflammatory cytokines from excess adipocytes may increase risk of HF32, 33. Also,
several mechanisms from animal models have been proposed for the cardiotoxic effect of fat
cells34. However, true obesity cardiomyopathy is uncommon, and usually occurs in cases of
extreme obesity (BMI ≥ 40 kg/m2) of greater than 10 years duration.
The main limitation of this study is our definition of HF. We included hospitalized and fatal
HF, as we did not have data on outpatient HF; however, community surveillance reports have
indicated that 74 % of outpatient HF cases are hospitalized within 1.7 years35. To address this
limitation, we performed a sensitivity analysis to explore the effect of nondifferential outcome
misclassification on our findings. As would be expected with outcome misclassification, we
found it should bias our findings toward the null and increase our uncertainty about the true
magnitude of the association.
This study is relevant and important to the understanding of the etiology of HF for three reasons.
First, the ARIC study is the largest population-based cohort study to evaluate the association
between WHR and waist circumference and incident HF. Furthermore, this is a well
characterized cohort with a long period of follow-up for which standardized methodology was
used. Because it is a large biracial study, we were able to describe this association stratified by
race and gender.
In conclusion, we observed that obesity was associated with incident HF and there was a graded
relation with body size. This association did not vary by race or gender. Selecting the best
anthropometric for the prediction of HF could have implications for the screening and
prevention of HF. The current study does not support the superiority of WHR or waist
circumference over BMI for the prediction of HF.
This is an important contribution to the literature on heart failure from a large population-
based bi-ethnic cohort study with a median of 16 years of follow-up for incident heart failure.
This paper adds to the existing literature by providing estimates for the association of
adiposity, as measured by three different anthropometric measures (body mass index, waist
hip ratio and waist circumference) with incident heart failure for African-Americans as well
as Whites. In most clinical settings, body mass index (BMI) is the sole adiposity metric that
is measured. This study evaluated whether these other measures were superior to BMI for
the determination of HF risk. In fact, our findings do not support waist circumference, waist-
hip ratio, or even further stratification of BMI into high and low categories of waist hip
ratio, as superior to BMI for the purpose of determining HF risk. Therefore, the potential
clinical impact is that measurement of waist circumference or waist hip ratio is not necessary
to improve determination of HF risk. This was true for both races (Whites and African-
Americans) and across gender.
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Graphical representation of race- and gender-stratified adjusted hazard ratios (95 % CI), for
overweight and obese as compared to referent* as measured by BMI (Panel A), waist
circumference (Panel B), and waist-hip ratio (Panel C), ARIC 1987-2004
*Referent categories were as follows: BMI, < 25; WHR, 1st tertile WHR; and waist
circumference, 1st tertile for waist circumference
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Age-adjusted (to mean age at baseline, 54 years) heart failure incidence rates (per 1,000)
person-years by categories of body mass index (BMI), stratified by waist-hip ratio (WHR),
(0.88 for women, 0.95 for men), ARIC 1987–2004
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Table 1
Characteristics at baseline (1987–1989) of those who did or did not develop heart failure, ARIC
Characteristics Incident Heart Failure (N =
1,528)
Non-cases (N = 13,113)
Age, mean (SD), years 56.8 (5.4) 53.8 (5.7)
Men, % 54 44
Black, % 34 25
Center, %
 Jackson, MS 31 22
 Forsyth County, NC 24 26
 Minneapolis, MN 17 27
 Washington County, MD 28 25
Educational level, %
 Less than high school 40 21
 High school graduate 30 33
 Greater than high school 30 46
Smoking status, %
 Never smoker 30 43
 Former smoker 33 32
 Current smoker 37 25
Alcohol use, %
 Never drinker 27 25
 Former drinker 28 17
 Current drinker 45 58
Diabetes, % 31 9
Hypertension, % 54 30
Left ventricular hypertrophy by ECG, % 7 2
History of coronary heart disease, % 14 3
 History of myocardial infarction, % 13 2
Plasma lipids, mean (SD), mmol/L
 Total cholesterol 5.70 (1.17) 5.55 (1.07)
 Low density lipoprotein cholesterol, (LDL-C) 3.71 (1.06) 3.55 (1.01)
 High density lipoprotein cholesterol, (HDL-C) 1.20 (0.41) 1.36 (0.44)
 Triglycerides 1.79 (1.34) 1.43 (0.95)
Anthropometric variables, mean (SD)
 Body mass index (BMI), kg/m2 29.7 (6.2) 27.3 (5.1)
 Waist circumference, cm 103.4 (15.0) 96.0 (13.3)
 Waist-hip ratio (WHR) 0.96 (0.07) 0.92 (0.08)
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